All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Hepatitis B, Chronic-23113154

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	23113154	A70P	S	S	Hepatitis B, Chronic	G R S L	View
2	23113154	A128V	S	S	Hepatitis B, Chronic	G R S L	View
3	23113154	A256T	S	S	Hepatitis B, Chronic	G R S L	View
4	23113154	A303C	S	S	Hepatitis B, Chronic	G R S L	View
5	23113154	A328G	S	S	Hepatitis B, Chronic	G R S L	View
6	23113154	A352G	S	S	Hepatitis B, Chronic	G R S L	View
7	23113154	A386G	S	S	Hepatitis B, Chronic	G R S L	View
8	23113154	A401T	S	S	Hepatitis B, Chronic	G R S L	View
9	23113154	A619C	S	S	Hepatitis B, Chronic	G R S L	View
10	23113154	C134A	S	S	Hepatitis B, Chronic	G R S L	View
11	23113154	C358T	S	S	Hepatitis B, Chronic	G R S L	View
12	23113154	C379A	S	S	Hepatitis B, Chronic	G R S L	View
13	23113154	C383T	S	S	Hepatitis B, Chronic	G R S L	View
14	23113154	C428T	S	S	Hepatitis B, Chronic	G R S L	View
15	23113154	C69X	S	S	Hepatitis B, Chronic	G R S L	View
16	23113154	C88A	S	S	Hepatitis B, Chronic	G R S L	View
17	23113154	E164D	S	S	Hepatitis B, Chronic	G R S L	View
18	23113154	F8L	S	S	Hepatitis B, Chronic	G R S L	View
19	23113154	G365A	S	S	Hepatitis B, Chronic	G R S L	View
20	23113154	G492T	S	S	Hepatitis B, Chronic	G R S L	View
21	23113154	G587T	S	S	Hepatitis B, Chronic	G R S L	View
22	23113154	G611T	S	S	Hepatitis B, Chronic	G R S L	View
23	23113154	I110V	S	S	Hepatitis B, Chronic	G R S L	View
24	23113154	I208T	S	S	Hepatitis B, Chronic	G R S L	View
25	23113154	I86F	S	S	Hepatitis B, Chronic	G R S L	View
26	23113154	L209X	S	S	Hepatitis B, Chronic	G R S L	View
27	23113154	L216X	S	S	Hepatitis B, Chronic	G R S L	View
28	23113154	L95W	S	S	Hepatitis B, Chronic	G R S L	View
29	23113154	P120S	S	S	Hepatitis B, Chronic	G R S L	View
30	23113154	P127T	S	S	Hepatitis B, Chronic	G R S L	View
31	23113154	Q101H	S	S	Hepatitis B, Chronic	G R S L	View
32	23113154	Q129R	S	S	Hepatitis B, Chronic	G R S L	View
33	23113154	Q30K	S	S	Hepatitis B, Chronic	G R S L	View
34	23113154	R122K	S	S	Hepatitis B, Chronic	G R S L	View
35	23113154	S143L	S	S	Hepatitis B, Chronic	G R S L	View
36	23113154	S204I	S	S	Hepatitis B, Chronic	G R S L	View
37	23113154	S207R	S	S	Hepatitis B, Chronic	G R S L	View
38	23113154	T118A	S	S	Hepatitis B, Chronic	G R S L	View
39	23113154	T135C	S	S	Hepatitis B, Chronic	G R S L	View
40	23113154	T207A	S	S	Hepatitis B, Chronic	G R S L	View
41	23113154	T22C	S	S	Hepatitis B, Chronic	G R S L	View
42	23113154	T284G	S	S	Hepatitis B, Chronic	G R S L	View
43	23113154	T45N	S	S	Hepatitis B, Chronic	G R S L	View
44	23113154	T623C	S	S	Hepatitis B, Chronic	G R S L	View
45	23113154	T626A	S	S	Hepatitis B, Chronic	G R S L	View
46	23113154	T647A	S	S	Hepatitis B, Chronic	G R S L	View
47	23113154	W196L	S	S	Hepatitis B, Chronic	G R S L	View
48	23113154	Y134F	S	S	Hepatitis B, Chronic	G R S L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.